| Tretinoin | Approved Investigational Nutraceutical | INPP1 | 3628 |
upregulated | Tretinoin results in increased expression of INPP1 mRNA | 2q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | INPP4B | 8821 |
upregulated | Tretinoin results in increased expression of INPP4B mRNA | 4q31.21 | |
| Tretinoin | Approved Investigational Nutraceutical | INPP5D | 3635 |
downregulated | Tretinoin results in decreased expression of INPP5D mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | INSIG1 | 3638 |
downregulated | Tretinoin results in decreased expression of INSIG1 mRNA | 7q36.3 | |
| Tretinoin | Approved Investigational Nutraceutical | INSL3 | 3640 |
downregulated | Tretinoin results in decreased expression of INSL3 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | INSM2 | 84684 |
downregulated | Tretinoin results in decreased expression of INSM2 mRNA | 14q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | INSR | 3643 |
upregulated | Tretinoin results in increased expression of INSR mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IPMK | 253430 |
upregulated | Tretinoin results in increased expression of IPMK mRNA | 10q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IPO4 | 79711 |
downregulated | Tretinoin results in decreased expression of IPO4 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | IPO5 | 3843 |
downregulated | Tretinoin results in decreased expression of IPO5 mRNA | 13q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IQCA1 | 79781 |
upregulated | Tretinoin results in increased expression of IQCA1 mRNA | 2q37.2-q37.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IQCD | 115811 |
downregulated | Tretinoin results in decreased expression of IQCD mRNA | 12q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | IQCE | 23288 |
downregulated | Tretinoin results in decreased expression of IQCE mRNA | 7p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IQCK | 124152 |
downregulated | Tretinoin results in decreased expression of IQCK mRNA | 16p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IQGAP2 | 10788 |
upregulated | Tretinoin results in increased expression of IQGAP2 mRNA | 5q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IRF1 | 3659 |
upregulated | Tretinoin results in increased expression of IRF1 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IRF2BPL | 64207 |
upregulated | Tretinoin results in increased expression of IRF2BPL mRNA | 14q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IRF3 | 3661 |
upregulated | Tretinoin results in increased expression of IRF3 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | IRF6 | 3664 |
downregulated | Tretinoin results in decreased expression of IRF6 mRNA | 1q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IRF7 | 3665 |
upregulated | Tretinoin results in increased expression of IRF7 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | IRF9 | 10379 |
upregulated | Tretinoin results in increased expression of IRF9 mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | IRS1 | 3667 |
downregulated | Tretinoin results in decreased expression of IRS1 mRNA | 2q36.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IRS2 | 8660 |
upregulated | Tretinoin results in increased expression of IRS2 mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | IRX1 | 79192 |
downregulated | Tretinoin results in decreased expression of IRX1 mRNA | 5p15.33 | |
| Tretinoin | Approved Investigational Nutraceutical | IRX3 | 79191 |
downregulated | Tretinoin results in decreased expression of IRX3 mRNA | 16q12.2 | |